Journal article
Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: The M77001 study group
M Marty, F Cognetti, D Maraninchi, R Snyder, L Mauriac, M Tubiana-Hulin, S Chan, D Grimes, A Anton, A Lluch, J Kennedy, K O'Byrne, P Conte, M Green, C Ward, K Mayne, JM Extra
Journal of Clinical Oncology | AMER SOC CLINICAL ONCOLOGY | Published : 2005